Terms: = Prostate cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Treatment
28 results:
1. [
Oprea-Lager DE; Gontier E; García-Cañamaque L; Gauthé M; Olivier P; Mitjavila M; Tamayo P; Robin P; García Vicente AM; Bouyeure AC; Bailliez A; Rodríguez-Fernández A; Mahmoud SB; Vallejo-Casas JA; Maksud P; Merlin C; Blanc-Durand P; Drouet C; Tissot H; Vierasu I; Vander Borght T; Boos E; Chossat F; Hodolic M; Rousseau C
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3439-3451. PubMed ID: 37341747
[TBL] [Abstract] [Full Text] [Related]
2. Using health insurance claims data to assess long-term disease progression in a prostate cancer cohort.
Khan S; Vohra S; Farnan L; Elmore SNC; Toumbou K; K C M; Fontham ETH; Peters ES; Mohler JL; Bensen JT
Prostate; 2022 Nov; 82(15):1447-1455. PubMed ID: 35880605
[TBL] [Abstract] [Full Text] [Related]
3. Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic prostate cancer.
Wallis CJD; Malone S; Cagiannos I; Morgan SC; Hamilton RJ; Basappa NS; Ferrario C; Gotto GT; Fernandes R; Niazi T; Noonan KL; Saad F; Hotte SJ; Hew H; Chan KFY; Wyllie LP; Shayegan B
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34926988
[TBL] [Abstract] [Full Text] [Related]
4. Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic prostate cancer: Evaluation of Clinical Biomarker Potential.
Bjerre MT; Nørgaard M; Larsen OH; Jensen SØ; Strand SH; Østergren P; Fode M; Fredsøe J; Ulhøi BP; Mortensen MM; Jensen JB; Borre M; Sørensen KD
Cells; 2020 May; 9(6):. PubMed ID: 32486483
[TBL] [Abstract] [Full Text] [Related]
5. Improved prostate cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ
Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369
[TBL] [Abstract] [Full Text] [Related]
6. Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced prostate cancer by Pre-existing Cardiovascular Comorbidities.
Lu-Yao G; Nikita N; Keith SW; Nightingale G; Gandhi K; Hegarty SE; Rebbeck TR; Chapman A; Kantoff PW; Cullen J; Gomella L; Kelly WK
Eur Urol; 2020 Feb; 77(2):158-166. PubMed ID: 31420248
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence and predictors of probable depression in prostate cancer survivors.
Erim DO; Bensen JT; Mohler JL; Fontham ETH; Song L; Farnan L; Delacroix SE; Peters ES; Erim TN; Chen RC; Gaynes BN
Cancer; 2019 Oct; 125(19):3418-3427. PubMed ID: 31246284
[TBL] [Abstract] [Full Text] [Related]
8. Prospective, Multisite, International Comparison of
Emmett L; Metser U; Bauman G; Hicks RJ; Weickhardt A; Davis ID; Punwani S; Pond G; Chua S; Ho B; Johnston E; Pouliot F; Scott AM
J Nucl Med; 2019 Jun; 60(6):794-800. PubMed ID: 30442757
[TBL] [Abstract] [Full Text] [Related]
9. Complementary Medicine, Refusal of Conventional cancer Therapy, and Survival Among Patients With Curable cancers.
Johnson SB; Park HS; Gross CP; Yu JB
JAMA Oncol; 2018 Oct; 4(10):1375-1381. PubMed ID: 30027204
[TBL] [Abstract] [Full Text] [Related]
10. Adjustable transobturator male system (ATOMS
Angulo JC; Fonseca J; Esquinas C; Ojea A; Rodríguez A; Rabassa M; Teba F; Escribano G; Cruz F
Actas Urol Esp (Engl Ed); 2018 Nov; 42(9):567-573. PubMed ID: 29929737
[TBL] [Abstract] [Full Text] [Related]
11. Comparative Analysis of Clinical Outcomes and Procedural Costs between the Conventional Two-stage Technique and 4D Brachytherapy for Early prostate cancer.
Langley SEM; Uribe J; Uribe-Lewis S; Money-Kyrle J; Perna C; Khaksar S; Soares R; Laing R
Clin Oncol (R Coll Radiol); 2018 Jan; 30(1):57-64. PubMed ID: 29054374
[TBL] [Abstract] [Full Text] [Related]
12. [PSMA-Radioguided Surgery for Salvage Lymphadenectomy in Recurrent prostate cancer].
Rauscher I; Eiber M; Maurer T
Aktuelle Urol; 2017 Apr; 48(2):148-152. PubMed ID: 28511221
[TBL] [Abstract] [Full Text] [Related]
13. PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro.
Martinez-Marin D; Jarvis C; Nelius T; de Riese W; Volpert OV; Filleur S
PLoS One; 2017; 12(4):e0174968. PubMed ID: 28403150
[TBL] [Abstract] [Full Text] [Related]
14. First evaluation of the feasibility of MLC tracking using ultrasound motion estimation.
Fast MF; O'Shea TP; Nill S; Oelfke U; Harris EJ
Med Phys; 2016 Aug; 43(8):4628. PubMed ID: 27487879
[TBL] [Abstract] [Full Text] [Related]
15. Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.
Kweldam CF; Kümmerlin IP; Nieboer D; Verhoef EI; Steyerberg EW; van der Kwast TH; Roobol MJ; van Leenders GJ
Mod Pathol; 2016 Jun; 29(6):630-6. PubMed ID: 26939875
[TBL] [Abstract] [Full Text] [Related]
16. Testosterone treatment and mortality in men with low testosterone levels.
Shores MM; Smith NL; Forsberg CW; Anawalt BD; Matsumoto AM
J Clin Endocrinol Metab; 2012 Jun; 97(6):2050-8. PubMed ID: 22496507
[TBL] [Abstract] [Full Text] [Related]
17. Dynamic delivery of IMRT using an independent collimator: a model study.
Zhang Y; Hu Y; Ma L; Dai J
Phys Med Biol; 2009 Apr; 54(8):2527-39. PubMed ID: 19336843
[TBL] [Abstract] [Full Text] [Related]
18. Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.
Mirochnik Y; Aurora A; Schulze-Hoepfner FT; Deabes A; Shifrin V; Beckmann R; Polsky C; Volpert OV
Clin Cancer Res; 2009 Mar; 15(5):1655-63. PubMed ID: 19223494
[TBL] [Abstract] [Full Text] [Related]
19. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
Haudenschild DR; Palmer SM; Moseley TA; You Z; Reddi AH
Cancer Res; 2004 Nov; 64(22):8276-84. PubMed ID: 15548695
[TBL] [Abstract] [Full Text] [Related]
20. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs.
Ashida S; Nakagawa H; Katagiri T; Furihata M; Iiizumi M; Anazawa Y; Tsunoda T; Takata R; Kasahara K; Miki T; Fujioka T; Shuin T; Nakamura Y
Cancer Res; 2004 Sep; 64(17):5963-72. PubMed ID: 15342375
[TBL] [Abstract] [Full Text] [Related]
[Next]
